Show simple item record

dc.contributor.authorStrati, P
dc.contributor.authorDe Vos, S
dc.contributor.authorRuan, J
dc.contributor.authorMaddocks, KJ
dc.contributor.authorFlowers, CR
dc.contributor.authorRule, Simon
dc.contributor.authorPatel, P
dc.contributor.authorXu, Y
dc.contributor.authorWei, H
dc.contributor.authorFrigault, MM
dc.contributor.authorCalvo, R
dc.contributor.authorDyer, MJS
dc.date.accessioned2022-03-07T14:26:24Z
dc.date.available2022-03-07T14:26:24Z
dc.date.issued2021-10
dc.identifier.issn0390-6078
dc.identifier.issn1592-8721
dc.identifier.urihttp://hdl.handle.net/10026.1/18909
dc.format.extent2774-2778
dc.format.mediumElectronic
dc.languageeng
dc.language.isoeng
dc.publisherFerrata Storti Foundation (Haematologica)
dc.subjectAntineoplastic Combined Chemotherapy Protocols
dc.subjectBenzamides
dc.subjectHumans
dc.subjectLymphoma, Large B-Cell, Diffuse
dc.subjectPyrazines
dc.titleAcalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study
dc.typejournal-article
dc.typeClinical Trial, Phase I
dc.typeLetter
dc.typeResearch Support, Non-U.S. Gov't
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000705005700011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue10
plymouth.volume106
plymouth.publication-statusPublished online
plymouth.journalHaematologica
dc.identifier.doi10.3324/haematol.2021.278654
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CCT&PS
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeItaly
dc.identifier.eissn1592-8721
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.3324/haematol.2021.278654
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV